1. Home
  2. RVPH vs FNWB Comparison

RVPH vs FNWB Comparison

Compare RVPH & FNWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • FNWB
  • Stock Information
  • Founded
  • RVPH 2006
  • FNWB 1923
  • Country
  • RVPH United States
  • FNWB United States
  • Employees
  • RVPH N/A
  • FNWB N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • FNWB Banks
  • Sector
  • RVPH Health Care
  • FNWB Finance
  • Exchange
  • RVPH Nasdaq
  • FNWB Nasdaq
  • Market Cap
  • RVPH 88.0M
  • FNWB 89.9M
  • IPO Year
  • RVPH N/A
  • FNWB 2015
  • Fundamental
  • Price
  • RVPH $2.09
  • FNWB $10.86
  • Analyst Decision
  • RVPH Strong Buy
  • FNWB Hold
  • Analyst Count
  • RVPH 5
  • FNWB 1
  • Target Price
  • RVPH $11.40
  • FNWB $12.00
  • AVG Volume (30 Days)
  • RVPH 1.8M
  • FNWB 16.2K
  • Earning Date
  • RVPH 11-14-2024
  • FNWB 01-29-2025
  • Dividend Yield
  • RVPH N/A
  • FNWB 2.59%
  • EPS Growth
  • RVPH N/A
  • FNWB N/A
  • EPS
  • RVPH N/A
  • FNWB N/A
  • Revenue
  • RVPH N/A
  • FNWB $50,900,000.00
  • Revenue This Year
  • RVPH N/A
  • FNWB N/A
  • Revenue Next Year
  • RVPH N/A
  • FNWB $11.60
  • P/E Ratio
  • RVPH N/A
  • FNWB N/A
  • Revenue Growth
  • RVPH N/A
  • FNWB N/A
  • 52 Week Low
  • RVPH $0.60
  • FNWB $8.91
  • 52 Week High
  • RVPH $4.83
  • FNWB $16.00
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 60.41
  • FNWB 60.31
  • Support Level
  • RVPH $1.78
  • FNWB $10.80
  • Resistance Level
  • RVPH $2.15
  • FNWB $11.10
  • Average True Range (ATR)
  • RVPH 0.15
  • FNWB 0.22
  • MACD
  • RVPH 0.02
  • FNWB 0.03
  • Stochastic Oscillator
  • RVPH 88.30
  • FNWB 75.00

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

Share on Social Networks: